Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

HFE mutations and hemochromatosis in Danish patients admitted for HFE genotyping

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Platelet function in lung cancer patients undergoing lobectomy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Platelet increment is not associated with endothelial damage in haematological patients: a prospective observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Change in HbA1c concentration as decision parameter for frequency of HbA1c measurement

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Relation between invasive hemodynamics and measured glomerular filtration rate by 51Cr-EDTA clearance in advanced heart failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Validation of plasma thyroxine and triiodothyronine methods on the ADVIA Centaur® XP

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Shared heritability and functional enrichment across six solid cancers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Diagnosis and Treatment of Genetic HFE-Hemochromatosis: The Danish Aspect

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997-2013: a nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Interventional cohort study of prolonged use (>72 hours) of paracetamol in neonates: protocol of the PARASHUTE study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Analysis of the common C282Y and H63D mutations in the HFE gene is widely used to diagnose hereditary hemochromatosis (HH). The aim of this study was to evaluate the efficiency with which different hospitals and general practitioners select patients for HH genotype and to determine the distribution of HFE mutations in such patients. Nine hundred unrelated patients from Danish hospitals and general practitioners (group A) and 69 consecutive patients from a specialized liver unit (group B) were examined for HFE substitutions using multiplex real-time polymerase chain reaction. In group A we found 13.0% (0%) C282Y homozygotes, 5.8% (2.6%) H63D/C282Y compound heterozygotes and 1.9% (3.1%) S65C heterozygotes. The values for 420 Danish blood donors are shown in parentheses. The distribution of genotypes in group B was similar to that of the blood donors. Serum ferritin, transferrin iron saturation and pathological data were collected from 38 randomly selected C282Y homozygotes, 36 H63D/C282Y compound heterozygotes, 19 H63D heterozygotes, 17 S65C heterozygotes and 144 wild-types. All of the C282Y homozygotes and 28% of the compound heterozygotes were diagnosed as HH patients. There was no evidence of HH in the H63D homozygotes or S65C heterozygotes. Moreover, 7 wild-type patients, 2 C282Y heterozygote patients and one H63D heterozygote patient fulfilled the criteria for HH. The significant enrichment of HH among associated genotype samples submitted for HFE testing indicates that the clinical selection is generally adequate. However, the study showed substantial deviation in the selection efficiency among the various hospitals and general practitioners.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Clinical and Laboratory Investigation
Vol/bind62
Udgave nummer7
Sider (fra-til)527-35
Antal sider9
ISSN0036-5513
StatusUdgivet - 2002

ID: 49582910